Vera Carlos, Córdova Andrés, Aburto Carla, Guerrero Cecilia, Suárez Sebastián, Illanes Andrés
School of Biochemical Engineering, Pontificia Universidad Católica de Valparaíso, Av. Brasil, 2085, Valparaíso, Chile.
School of Food Engineering, Pontificia Universidad Católica de Valparaíso, Waddington 716, Playa Ancha, Valparaíso, Chile.
World J Microbiol Biotechnol. 2016 Dec;32(12):197. doi: 10.1007/s11274-016-2159-4. Epub 2016 Oct 18.
Lactose-derived non-digestible oligosaccharides are prominent components of functional foods. Among them, galacto-oligosaccharides (GOS) outstand for being prebiotics whose health-promoting effects are supported on strong scientific evidences, having unique properties as substitutes of human milk oligosaccharides in formulas for newborns and infants. GOS are currently produced enzymatically in a kinetically-controlled reaction of lactose transgalactosylation catalyzed by β-galactosidases from different microbial strains. The enzymatic synthesis of GOS, although being an established technology, still offers many technological challenges and opportunities for further development that has to be considered within the framework of functional foods which is the most rapidly expanding market within the food sector. This paper presents the current technological status of GOS production, its main achievements and challenges. Most of the problems yet to be solved refer to the rather low GOS yields attainable that rarely exceed 40 %, corresponding to lactose conversions around 60 %. This means that the product or reaction (raw GOS) contains significant amounts of residual lactose and monosaccharides (glucose and galactose). Efforts to increase such yields have been for the most part unsuccessful, even though improvements by genetic and protein engineering strategies are to be expected in the near future. Low yields impose a burden on downstream processing to obtain a GOS product of the required purity. Different strategies for raw GOS purification are reviewed and their technological significance is appraised.
乳糖衍生的不可消化低聚糖是功能性食品的重要成分。其中,低聚半乳糖(GOS)作为益生元脱颖而出,其促进健康的作用有强有力的科学证据支持,在新生儿和婴儿配方奶粉中作为人乳低聚糖的替代品具有独特性质。目前,GOS是通过不同微生物菌株的β-半乳糖苷酶催化乳糖转半乳糖基化的动力学控制反应酶法生产的。GOS的酶法合成虽然是一项成熟技术,但仍面临诸多技术挑战,也有进一步发展的机遇,这些都必须在功能性食品框架内加以考虑,功能性食品是食品行业中发展最迅速的市场。本文介绍了GOS生产的当前技术状况、主要成果和挑战。大多数有待解决的问题都与GOS产量较低有关,产量很少超过40%,乳糖转化率约为60%。这意味着产品或反应(粗GOS)含有大量残留乳糖和单糖(葡萄糖和半乳糖)。提高产量的努力大多没有成功,尽管预计在不久的将来通过基因和蛋白质工程策略会有所改进。低产量给下游加工带来负担,难以获得所需纯度的GOS产品。本文综述了粗GOS纯化的不同策略,并评估了它们的技术意义。